- Home
- IZM vs TPST Comparison
IZM vs TPST Comparison
Compare IZM & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- TPST
- Stock Information
- Founded
- IZM 2011
- TPST 2011
- Country
- IZM China
- TPST United States
- Employees
- IZM N/A
- TPST N/A
- Industry
- IZM Consumer Electronics/Video Chains
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- TPST Health Care
- Exchange
- IZM Nasdaq
- TPST Nasdaq
- Market Cap
- IZM 24.9M
- TPST 27.2M
- IPO Year
- IZM 2023
- TPST N/A
- Fundamental
- Price
- IZM $2.21
- TPST $0.89
- Analyst Decision
- IZM
- TPST Strong Buy
- Analyst Count
- IZM 0
- TPST 4
- Target Price
- IZM N/A
- TPST $20.00
- AVG Volume (30 Days)
- IZM 41.3K
- TPST 3.3M
- Earning Date
- IZM 11-26-2024
- TPST 11-12-2024
- Dividend Yield
- IZM N/A
- TPST N/A
- EPS Growth
- IZM N/A
- TPST N/A
- EPS
- IZM N/A
- TPST N/A
- Revenue
- IZM $177,933,890.00
- TPST N/A
- Revenue This Year
- IZM N/A
- TPST N/A
- Revenue Next Year
- IZM N/A
- TPST N/A
- P/E Ratio
- IZM N/A
- TPST N/A
- Revenue Growth
- IZM N/A
- TPST N/A
- 52 Week Low
- IZM $1.86
- TPST $0.83
- 52 Week High
- IZM $52.21
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- IZM 48.08
- TPST 34.45
- Support Level
- IZM $2.10
- TPST $0.94
- Resistance Level
- IZM $2.34
- TPST $1.16
- Average True Range (ATR)
- IZM 0.09
- TPST 0.10
- MACD
- IZM 0.02
- TPST 0.00
- Stochastic Oscillator
- IZM 57.43
- TPST 15.50
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.